News & Updates
Filter by Specialty:
Ensifentrine improves lung function, cuts exacerbations in COPD
04 Dec 2023
byAudrey Abella
The novel, selective, dual PDE*3 and PDE4 inhibitor ensifentrine improved lung function and reduced exacerbations in individuals with chronic obstructive pulmonary disease (COPD), findings from the ENHANCE**-1 and ENHANCE-2 trials have shown.
Ensifentrine improves lung function, cuts exacerbations in COPD
04 Dec 2023Gastrointestinal issues linger long after COVID-19 recovery
04 Dec 2023
Gut-brain interaction disorders and persistent gastrointestinal (GI) symptoms prevail 12–18 months following COVID-19 hospitalization, and these prolonged GI issues are associated with the severity of the symptoms during hospitalization and the psychological toll of the illness experience, according to a study.
Gastrointestinal issues linger long after COVID-19 recovery
04 Dec 2023Slow walk pace, weight gain up CKD risk in adults with obesity
03 Dec 2023
Weight gain and a slow walking pace both influence the risk of chronic kidney disease among adults with obesity who do not have diabetes at baseline, results of a study have shown.